Bausch Health Companies | VRX - Selling And Administration Expenses

Stock Price
7.84
Daily Change
-0.05 -0.63%
Monthly
-23.21%
Yearly
-24.62%
Q1 Forecast
7.62

Bausch Health Companies reported $795M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Amgen USD 1.7B 9M Sep/2025
ANI Pharmaceuticals USD 76.66M 5.11M Sep/2025
Aurora Cannabis CAD 41.79M 3.84M Sep/2025
Bausch Health Companies USD 795M 99M Sep/2025
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 1.79B 76M Sep/2025
Canopy Growth CAD 29.53M 999K Sep/2025
Corcept Therapeutics USD 106.97M 3.12M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Drreddys Laboratories INR 26.92B 3.74B Dec/2025
Eli Lilly USD 2.74B 12.3M Sep/2025
Gilead Sciences USD 1.35B 6M Sep/2025
Novo Nordisk DKK 18.85B 2.74B Jun/2025
Pacira USD 91.8M 14.6M Sep/2025
Perrigo USD 245.7M 27.4M Sep/2025
Prestige Brands USD 28.04M 419K Sep/2025
Supernus Pharmaceuticals USD 179.68M 117.46M Sep/2025
Vertex Pharmaceuticals USD 445.1M 20.5M Sep/2025
Zoetis USD 579M 29M Sep/2025